A detailed history of Wellington Shields & Co., LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Wellington Shields & Co., LLC holds 8,376 shares of MRNA stock, worth $994,650. This represents 0.3% of its overall portfolio holdings.

Number of Shares
8,376
Previous 5,806 44.26%
Holding current value
$994,650
Previous $577,000 54.59%
% of portfolio
0.3%
Previous 0.21%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 23, 2024

BUY
$85.37 - $115.44 $219,400 - $296,680
2,570 Added 44.26%
8,376 $892,000
Q1 2024

May 23, 2024

SELL
$85.37 - $115.44 $219,400 - $296,680
-2,570 Reduced 30.68%
5,806 $618,000
Q1 2024

May 03, 2024

BUY
$85.37 - $115.44 $219,400 - $296,680
2,570 Added 44.26%
8,376 $892,000
Q4 2023

Feb 09, 2024

SELL
$69.51 - $104.43 $56,998 - $85,632
-820 Reduced 12.38%
5,806 $577,000
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $255,968 - $336,149
2,655 Added 66.86%
6,626 $684,000
Q2 2023

Aug 11, 2023

SELL
$118.5 - $160.53 $50,836 - $68,867
-429 Reduced 9.75%
3,971 $482,000
Q1 2023

May 11, 2023

BUY
$135.66 - $197.02 $3,255 - $4,728
24 Added 0.55%
4,400 $675,000
Q4 2022

Feb 14, 2023

SELL
$118.38 - $210.04 $110,093 - $195,337
-930 Reduced 17.53%
4,376 $786,000
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $16,057 - $26,408
-136 Reduced 2.5%
5,306 $627,000
Q2 2022

Aug 12, 2022

BUY
$117.13 - $176.59 $241,873 - $364,658
2,065 Added 61.15%
5,442 $777,000
Q1 2022

May 09, 2022

BUY
$126.46 - $235.05 $170,088 - $316,142
1,345 Added 66.19%
3,377 $582,000
Q4 2021

Feb 15, 2022

BUY
$225.82 - $368.51 $458,866 - $748,812
2,032 New
2,032 $516,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $46.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Wellington Shields & Co., LLC Portfolio

Follow Wellington Shields & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields & Co., LLC with notifications on news.